Caspase 5, Control Peptide (Caspase-5, CASP 5, CASP5, CASP-5, ICERELIII, ICErel-III, Ich3, Ich-3 Protease, TY, TY Protease)

Cat# 146958-50ug

Size : 50ug

Brand : US Biological

Request more information

Contact local distributor :


Phone : +1 850 650 7790


146958 Caspase 5, Control Peptide (Caspase-5, CASP 5, CASP5, CASP-5, ICERELIII, ICErel-III, Ich3, Ich-3 Protease, TY, TY Protease)

Clone Type
Polyclonal
Grade
Purified
Applications
E
Shipping Temp
Blue Ice
Storage Temp
-20°C

Control Peptide for 146035.||Source:|Synthetic peptide corresponding to 14aa from human Caspase-5.||Applications:|Suitable for use in ELISA and Antibody Blocking. Other applications not tested.||Recommended Dilution:|Optimal dilutions to be determined by the researcher.||Storage and Stability:|May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing.. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Applications
Source: Synthetic peptide |Purity: Purified|Concentration: ~0.2mg/ml|Form: Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide.
Purity
Purified
References
1. Schwartz MN. Recognition and management of anthrax an update. New Engl. J. Med. 2001; 345:1621-6. 2. Moayeri M and Leppla SH. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol. 2004; 7:19-24. 3. Bradley KA, Mogridge J, Mourez M, et al. Identification of the cellular receptor for anthrax toxin. Nature 2001; 414:225-9. 4. Scobie HM, Rainey GJ, Bradley KA, et al. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 2003; 100:5170-4.